Cargando…

Factors Associated with Glycemic Variability in Patients with Type 2 Diabetes: Focus on Oral Hypoglycemic Agents and Cardiovascular Risk Factors

BACKGROUND: The role of glycemic variability (GV) in development of cardiovascular diseases remains controversial, and factors that determine glucose fluctuation in patients with diabetes are unknown. We investigated relationships between GV indices, kinds of oral hypoglycemic agents (OHAs), and car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Soyeon, Chin, Sang-Ouk, Lee, Sang-Ah, Koh, Gwanpyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595361/ https://www.ncbi.nlm.nih.gov/pubmed/26248860 http://dx.doi.org/10.3803/EnM.2015.30.3.352

Ejemplares similares

The Change in Glucagon Following Meal Ingestion Is Associated with Glycemic Control, but Not with Incretin, in People with Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2021)

Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus
por: Lee, Sang Ah, et al.
Publicado: (2016)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
por: Bang, Jisun, et al.
Publicado: (2023)

Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus
por: Yoo, Soyeon, et al.
Publicado: (2019)

Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes
por: Lim, Younghyup, et al.
Publicado: (2015)

SUN-145 Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes
por: Yoo, Soyeon, et al.
Publicado: (2019)

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
por: Oh, SuA, et al.
Publicado: (2022)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Glycemic Variability Correlates Strongly With Postprandialβ-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents
por: Kohnert, Klaus-Dieter, et al.
Publicado: (2009)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
por: Bianchi, Cristina, et al.
Publicado: (2009)

Adherence to Oral Hypoglycemic Agents in Hawaii
por: Lee, Rachel, et al.
Publicado: (2005)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
por: Moon, Jaecheol, et al.
Publicado: (2020)

Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs
por: Luo, Menghui, et al.
Publicado: (2020)

Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients
por: Khan, Mohd Idreesh, et al.
Publicado: (2013)

Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes
por: Moon, Jaecheol, et al.
Publicado: (2020)

Oral hypoglycemic agents: do the ends justify the means?
por: Langer, Oded
Publicado: (2015)

Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
por: Kim, Bo-Yeon, et al.
Publicado: (2011)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Latent autoimmune diabetes of adults: From oral hypoglycemic agents to early insulin
por: Poudel, Resham R.
Publicado: (2012)

Drug-drug interaction between voriconazole and oral hypoglycemic agents in diabetic rats
por: Kumar, Boyina Hemanth, et al.
Publicado: (2013)

Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes
por: Irani, Mahtab, et al.
Publicado: (2021)

Cardiovascular Risk Factors: It's Time to Focus on Variability!
por: Barnett, Mallory P., et al.
Publicado: (2020)

Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy
por: Cho, Eun Hyung, et al.
Publicado: (2018)

Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
por: Bashir, Mir Iftikhar, et al.
Publicado: (2012)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults
por: Bakouni, Hamzah, et al.
Publicado: (2019)

Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient‐ and physician‐related factors): A prospective observational DIPP‐FACTOR study in Korea
por: Kim, Sin Gon, et al.
Publicado: (2017)

The Role of Glycemic Variability in Cardiovascular Disorders
por: Alfieri, Valentina, et al.
Publicado: (2021)

Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-Related Factors in Health Screen Examinees (J Obes Metab Syndr 2017;26:188–96)
por: Koh, Gwanpyo
Publicado: (2018)

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
por: Jun, Ji Eun, et al.
Publicado: (2015)

Letter: Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study (J Obes Metab Syndr 2022;31:178-86)
por: Koh, Gwanpyo
Publicado: (2023)

The Management of Type 2 Diabetic Patients with Hypoglycemic Agents
por: Carnevale Schianca, G. P., et al.
Publicado: (2012)

Cognition and drug adherence to oral hypoglycemic and antihypertensive agents in older adults [Corrigendum]
Publicado: (2019)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Characteristics of Subjects with Very Low Serum Low-Density Lipoprotein Cholesterol and the Risk for Intracerebral Hemorrhage
por: Lee, Jae-Geun, et al.
Publicado: (2012)

Use of pharmacy dispensing data to measure adherence and identify nonadherence with oral hypoglycemic agents
por: Sodihardjo-Yuen, Fong, et al.
Publicado: (2016)

Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
por: Moon, Jun Sung, et al.
Publicado: (2021)

Bioactives of Momordica charantia as Potential Anti-Diabetic/Hypoglycemic Agents
por: Xu, Bilin, et al.
Publicado: (2022)

Hypoglycemic agents and potential anti-inflammatory activity
por: Kothari, Vishal, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_35c7fnmdv9ivkvqtpjlonnptgr